img

Global Gastrointestinal Stromal Tumor Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gastrointestinal Stromal Tumor Market Research Report 2024

Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
According to MRAResearch’s new survey, global Gastrointestinal Stromal Tumor market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gastrointestinal Stromal Tumor market research.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gastrointestinal Stromal Tumor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
​​Sun Pharmaceutical
Pfizer
Bayer Aktiengesellschaft
NATCO Pharma
Segment by Type
Stomach
Small Intestine
Others

Segment by Application


Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gastrointestinal Stromal Tumor report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Stomach
1.2.3 Small Intestine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialized Cancer Treatment Centers
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2018-2033)
2.2 Gastrointestinal Stromal Tumor Growth Trends by Region
2.2.1 Global Gastrointestinal Stromal Tumor Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastrointestinal Stromal Tumor Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2024-2033)
2.3 Gastrointestinal Stromal Tumor Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2018-2023)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2022
3.5 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2024-2033)
5 Gastrointestinal Stromal Tumor Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2018-2033)
6.2 North America Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
6.4 North America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2018-2033)
7.2 Europe Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
7.4 Europe Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size (2018-2033)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Market Size (2018-2033)
9.2 Latin America Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
9.4 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size (2018-2033)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 ​​Sun Pharmaceutical
11.2.1 ​​Sun Pharmaceutical Company Detail
11.2.2 ​​Sun Pharmaceutical Business Overview
11.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
11.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.2.5 ​​Sun Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Detail
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.4.5 Bayer Aktiengesellschaft Recent Development
11.5 NATCO Pharma
11.5.1 NATCO Pharma Company Detail
11.5.2 NATCO Pharma Business Overview
11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.5.5 NATCO Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Stomach
Table 3. Key Players of Small Intestine
Table 4. Key Players of Others
Table 5. Global Gastrointestinal Stromal Tumor Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Gastrointestinal Stromal Tumor Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gastrointestinal Stromal Tumor Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gastrointestinal Stromal Tumor Market Share by Region (2018-2023)
Table 9. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gastrointestinal Stromal Tumor Market Share by Region (2024-2033)
Table 11. Gastrointestinal Stromal Tumor Market Trends
Table 12. Gastrointestinal Stromal Tumor Market Drivers
Table 13. Gastrointestinal Stromal Tumor Market Challenges
Table 14. Gastrointestinal Stromal Tumor Market Restraints
Table 15. Global Gastrointestinal Stromal Tumor Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gastrointestinal Stromal Tumor Market Share by Players (2018-2023)
Table 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2022)
Table 18. Ranking of Global Top Gastrointestinal Stromal Tumor Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gastrointestinal Stromal Tumor Product Solution and Service
Table 22. Date of Enter into Gastrointestinal Stromal Tumor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2018-2023)
Table 26. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2024-2033)
Table 28. Global Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2018-2023)
Table 30. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2024-2033)
Table 32. North America Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Gastrointestinal Stromal Tumor Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Gastrointestinal Stromal Tumor Product
Table 50. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. ​​Sun Pharmaceutical Company Detail
Table 53. ​​Sun Pharmaceutical Business Overview
Table 54. ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Product
Table 55. ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 56. ​​Sun Pharmaceutical Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Gastrointestinal Stromal Tumor Product
Table 60. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Bayer Aktiengesellschaft Company Detail
Table 63. Bayer Aktiengesellschaft Business Overview
Table 64. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product
Table 65. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 66. Bayer Aktiengesellschaft Recent Development
Table 67. NATCO Pharma Company Detail
Table 68. NATCO Pharma Business Overview
Table 69. NATCO Pharma Gastrointestinal Stromal Tumor Product
Table 70. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 71. NATCO Pharma Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumor Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gastrointestinal Stromal Tumor Market Share by Type: 2022 VS 2033
Figure 3. Stomach Features
Figure 4. Small Intestine Features
Figure 5. Others Features
Figure 6. Global Gastrointestinal Stromal Tumor Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Gastrointestinal Stromal Tumor Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Specialized Cancer Treatment Centers Case Studies
Figure 11. Other End Users Case Studies
Figure 12. Gastrointestinal Stromal Tumor Report Years Considered
Figure 13. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Gastrointestinal Stromal Tumor Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Gastrointestinal Stromal Tumor Market Share by Region: 2022 VS 2033
Figure 16. Global Gastrointestinal Stromal Tumor Market Share by Players in 2022
Figure 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2022
Figure 19. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 21. United States Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 25. Germany Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Region (2018-2033)
Figure 33. China Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 41. Mexico Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 45. Turkey Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 48. ​​Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 50. Bayer Aktiengesellschaft Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 51. NATCO Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed